The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...

International Business Machines said Thursday that it had joined forces with Moderna for a case study that evidenced quantum ...

Investment firms have issued research reports regarding IBM's earnings release, including RBC Capital, which raised its price ...

Moderna’s partnership with IBM — a technology company that specializes in AI and hybrid cloud — will include investments in generative AI to improve product design.

IBM and Moderna announced a new partnership today to explore the potential of generative AI and quantum computing.

Under this initiative, Moderna and IBM will combine state-of-the-art formulation discovery with generative AI to design mRNA medicines with optimal safety and performance.

Biotech giant Moderna is partnering with IBM to explore the use of quantum computing and artificial intelligence for mRNA research. Through the partnership, Moderna will have access to IBM’s ...

Moderna’s partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine.

IBM is seeking a long-term partnership with Japan's Rapidus to develop sub-1nm chips, according to . Building on their 2nm collaboration, IBM has deployed engineers to Rapidus's Hokkaido site ...

IBM refers to the model as one that can “learn the grammar of molecules.” “We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of ...

"IBM's purpose is to be the catalyst to make the world work better, perfectly exemplified by this partnership with Moderna. We are witnessing a revolution in the world of computing, driven by ...